FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, particularly to pharmaceutical industry, and describes a dosage form of Clopidogrel presented in the form of a solid gelatine capsule. The dosage form contains Clopidogrel hydrogen sulphate, lactose anhydride, microcrystalline cellulose, sodium croscarmellose, colloidal silicon dioxide and magnesium stearate.
EFFECT: according to the invention, the dosage form of Clopidogrel contains a high amount of the active ingredient; it is prepared without the use of a wet granulation technique, and provides the more accurate dosage of the ingredients and the stability of the substances used.
9 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID DOSAGE FORM OF CLOPIDOGREL AND METHOD FOR PREPARING THEREOF | 2009 |
|
RU2393862C1 |
| COMBINED MEDICINE AS THROMBOCYTE AGGREGATION INHIBITOR | 2011 |
|
RU2484820C2 |
| COMBINED HYPOTENSIVE DRUG | 2010 |
|
RU2444371C1 |
| HYPOLIPIDEMIC DOSAGE FORM AND METHOD FOR PREPARING IT | 2013 |
|
RU2547574C2 |
| PHARMACEUTICAL COMPOSITION IN FORM OF TABLET AND METHOD OF OBTAINING THEREOF | 2014 |
|
RU2546002C1 |
| PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN | 2008 |
|
RU2484816C2 |
| COMBINED REMEDY FOR IMPROVING THE FUNCTIONAL STATE OF THE BRAIN | 2021 |
|
RU2782672C1 |
| SOLID MEDICINAL COMPOSITION COMPRISING DERIVATIVE OF PIPERAZINOUREA | 2002 |
|
RU2311172C2 |
| ORAL PHARMACEUTICAL COMPOSITION OF DIURETICS AND ACE INHIBITOR IN MICRONIZED FORM, DRUG AND ITS APPLICATION | 2012 |
|
RU2618471C2 |
| PELLETISED CLOPIDOGREL OR ITS PHARMACEUTICALLY ACCEPTABLE SALT FORMULATION, METHOD OF OBTAINMENT AND APPLICATION | 2007 |
|
RU2349304C1 |
